Today’s posts that caught my eye:
The battle to provide obesity treatments jumped to a new level on Monday, with Eli Lilly announcing that an experimental drug that acts on three hormones (rather than the single target in Novo Nordisk’s Wegovy) led to the greatest weight loss yet seen by a new generation of drugs. The weekly injectable, called retatruti…
Keep reading with a 7-day free trial
Subscribe to Chris Riback's Newsletter to keep reading this post and get 7 days of free access to the full post archives.